Leadership Team and Advisors
Leadership Team
Dr. Gupta earned his bachelor’s degree in Mathematics from the University of Chicago and a PhD in Cancer Biology from MIT. Dr. Gupta was a member of the Whitehead Institute for Biomedical Research and an Associate Professor of Biology at MIT. Dr. Gupta previously co-founded Verastem Oncology, based on his scientific research at MIT and served as a Director on its corporate board from the company’s founding through multiple rounds of venture capital financing and an initial public offering. His research has appeared in leading scientific journals and received international acclaim, including coverage by the MIT Technology Review, Bloomberg News, and as a lead story in the The New York Times.
James McNally is the Chief Executive Officer for Naveris. Previously, he was President and CEO of Digma Medical, a clinical stage medical device company developing novel therapeutics for metabolic disease. He has served as Sr. Vice President, Sales, Marketing, & Business Development, for GenMark Diagnostics (acquired by Roche) where he led the launch of the ePlex multiplex molecular diagnostics platform. He has also held roles in general management, sales, marketing, R&D, and corporate finance at Volcano Corp. (acquired by Philips), Boston Scientific, and Morgan Stanley. James graduated magna cum laude from Princeton University, holds a M.S. degree from the University of Arizona, and earned an M.B.A. from Harvard Business School where he was a Baker Scholar and a Kaplan Life Sciences Fellow.
Dr. Berger was the Chief Medical Officer for Exact Sciences Corporation for 20 years, and developed advanced DNA based tests for colorectal cancer screening. Prior to Exact Sciences, Dr. Berger’s clinical career was spent at the Department of Pathology and Laboratory Medicine of Harvard Pilgrim Healthcare. Dr. Berger is the past chairman of the Advisory Committee on Clinical Laboratories for the Commonwealth of Massachusetts and is a currently serves on the executive committee of the Massachusetts Society of Pathologists and the Policy Committee of the National Colorectal Cancer Roundtable. He has served as a panelist for the Medicare Evidence Development and Coverage Advisory Committee. He received his MD from the University of Pennsylvania where he also completed a post-doctoral fellowship in Immunology with Dr. Peter Nowell. Following a medical internship at Boston University Hospital, and two years as a general medical officer in the U.S. Air Force, he served as a resident and chief resident in Pathology at Brigham and Women’s Hospital.
Dr. Naber is Laboratory and Medical Director. Dr. Naber is a board-certified anatomic pathologist with expertise in cancer diagnostics. Prior to joining Naveris, Dr. Naber served as the Chief of Pathology at Tufts Medical Center and was Director of its CLIA & CAP accredited diagnostic lab. Dr. Naber serves as an Associate Chair in the Department of Pathology at Tufts University School of Medicine, and has had a long and illustrious teaching and research career spanning more than two decades. He serves as a member of scientific advisory board of BioLegend CNS, Inc. He has received several National Institutes of Health and Department of Defense grants and awards for studies in studies of breast neoplasia, models of tumor development, and regulation of gene expression in human breast cancer. Dr. Naber received his MD from St. Louis University School of Medicine and his PhD in Physiology from the University of Houston.
Michael Hicks is the SVP Commercialization Operations for NavDx, the flagship product at Naveris. Michael leads all NavDx Commercialization efforts and is responsible for sales, marketing, market access and billing. Michael comes to Naveris with deep expertise in diagnostic and pharma industries and developing high-performing organizations and profitable commercial strategies that launch products, penetrate new markets and drive consistent revenue growth. Prior to joining Naveris, Michael was a senior leader with MDx Health, Genomic Health, Bayer Healthcare, and Bristol-Myers Squibb.
Dorina Kabashi is the Vice President of Finance for Naveris. She has two decades of experience as finance and accounting leader. Most recently, she was the Vice President of Finance of Hydrow, a connected fitness start-up, where she supported the company’s exponential growth during the pandemic. Previously, Dorina held senior finance leadership roles at Houghton Mifflin Harcourt and also spent over 13 years at Ernst & Young where she served a number of medical device and life science companies either as an auditor or as a financial advisor. She is a Certified Public Accountant and holds an MBA from Texas A&M International University.
Erik Duffy is the Vice President of Market Access where he plays a critical role in commercialization of Naveris products. In addition to Market Access, Erik oversees billing and regulatory operations. He brings 20 years of industry experience with 10 of those years in the cancer space. Prior to joining Naveris, Erik worked with Exact Sciences and Promethius Laboratories holding a variety of roles in sales, leadership and market access. When not working, Erik enjoys his family of 5 and all his kid’s sports activities. He enjoys coaching soccer and working with young athletes.
Ben Pricer is the Vice President of Business Operations at Naveris, Inc., where he leads initiatives to expand awareness of the NavDx test and to optimize systems that improve both provider and patient experience. He brings more than 20 years of experience in commercial operations spanning life science research tools and molecular diagnostics. Before joining Naveris, Ben served as Global Head of Sales and Marketing at SCHOTT MINIFAB, where he led growth initiatives in life science contract manufacturing. He previously held senior leadership roles at LumiraDx, GenMark Diagnostics (acquired by Roche), Illumina, and Agilent Technologies, where he built and scaled commercial teams, launched innovative diagnostic solutions, and developed systems to improve operational efficiency and market adoption. Ben earned a Bachelor of Science in Biology from the University of California, San Diego. He is passionate about advancing access to cutting-edge diagnostic technologies and empowering providers to deliver better patient outcomes.
Chloe Wiseman is the Associate Vice President of Laboratory Operations at Naveris, where she leads cross-functional teams in advancing diagnostic laboratory capabilities for early cancer detection. With over 15 years of experience in laboratory operations, clinical diagnostics, and quality management, Chloe has a proven track record of driving process improvements, ensuring regulatory compliance, and implementing novel technologies. Prior to Naveris, she held leadership roles at Labcorp in St. Vincent’s Hospital, overseeing core lab operations, assay validation, and team development. Chloe is a certified Medical Laboratory Scientist (ASCP-MLS) and holds a Bachelor of Science in Medical Laboratory Science from the University of Kentucky, graduating summa cum laude. Her expertise spans CAP and CLIA compliance, GLP, laboratory information system implementation, and mentoring future leaders in laboratory medicine. She is passionate about elevating laboratory standards and fostering innovation to improve patient outcomes.
Natalie Thurston RN, MBA, CPHQ leads our Reimbursement team at Naveris, Inc. Natalie joined Naveris in December 2023. As Vice President, Natalie oversees all billing and appeals operations and contract implementation.
Natalie is a reimbursement professional with over two decades of experience. Natalie has a unique perspective on reimbursement matters, having worked for both a large national health plan (Humana) and national providers of molecular diagnostic laboratory services including CareDx and Lucid Diagnostics. Natalie also spent time consulting independently and with Aledo Consulting. Natalie has used her knowledge of reimbursement practices of payor organizations to obtain positive coverage decisions for products from both commercial and government payor organizations. Natalie received a bachelor's of Nursing (BSN) from Indiana University- Indianapolis and Master's in Business Administration (MBA from Indiana University Southeast. She also maintains a certification in Healthcare Quality (CPHQ).